AI assistant
Sending…
Coloplast — Director's Dealing 2016
May 25, 2016
3358_rns_2016-05-25_404873e7-a88f-481e-8aec-f84702e7ccd3.pdf
Director's Dealing
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}
C
Coloplast
Ostomy care
Urology & Continence care
Wound & Skin care
Nasdaq Nordic
25 May 2016
Coloplast A/S
Holtedam 1
DK-3050 Humlebæk
Denmark
Tel: +45 4911 1111
www.coloplast.com
CVR No. 69749917
Report on transactions of executives and related parties in Coloplast shares and related securities
According to the Danish Securities Act § 28a Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.
The below transaction concerns purchase and sale of shares.
| Name | Aage og Johanne Louis-Hansen ApS |
|---|---|
| Reason | Related party (company) |
| Issuer | Coloplast A/S |
| ISIN code | DK0060448595 |
| Description | Shares |
| Transaction | Purchase of shares |
| Trade date | 24 May 2016 |
| Market | Nasdaq Nordic |
| Number | 40,000 A shares |
| Share price in DKK | 495.50 |
| Market value in DKK | 19,820,000 |
| Name | Aage og Johanne Louis-Hansen ApS |
| --- | --- |
| Reason | Related party (company) |
| Issuer | Coloplast A/S |
| ISIN code | DK0060448595 |
| Description | Shares |
| Transaction | Sale of shares |
| Trade date | 24 May 2016 |
| Market | Nasdaq Nordic |
| Number | 12,710 B shares |
| Share price in DKK | 495.50 |
| Market value in DKK | 6,297,805 |
Kind regards,
Coloplast A/S
Anne-Sofie Søegaard
This information is available in Danish and in English, in case of doubt the Danish version prevails.
For further information: Anne-Sofie Søegaard, tel. +45 4911 1924.
More from Coloplast
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Earnings Release
2026
Apr 23
Earnings Release
2026
Apr 23
Earnings Release
2026
Apr 23
Earnings Release
2026
Apr 23